CAPTRUST Financial Advisors’s Tenaya Therapeutics TNYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.12K Hold
13,459
– – ﹤0.01% 3357
2026
Q2
$9.9K Buy
+13,459
New +$10.2K ﹤0.01% 3239
2025
Q3
– Sell
-13,566
Closed -$8.29K – 2718
2025
Q2
$8.29K Sell
13,566
-915
-6% -$466 ﹤0.01% 2501
2025
Q1
$8.26K Buy
+14,481
New +$14.3K ﹤0.01% 2342
2021
Q4
– Sell
-26
Closed -$1K – 4905
2021
Q3
$1K Buy
+26
New +$559 ﹤0.01% 4488

Other funds holding TNYA

CAPTRUST Financial Advisors's TNYA Position: Q3 2026 in Review

CAPTRUST Financial Advisors held its Tenaya Therapeutics (TNYA) position steady in Q3 2026 at 13,459 shares worth $8.12K. The position accounts for ﹤0.01% of the portfolio, ranked #3357.

CAPTRUST Financial Advisors first reported a position in TNYA in Q3 2021 and has held it in 5 quarters since. The position peaked at $9.9K in Q2 2026. 94 funds tracked by Wall St. Rank hold TNYA as of Q3 2026.

  • CAPTRUST Financial Advisors held 13,459 shares of Tenaya Therapeutics worth $8.12K as of Q3 2026.
  • CAPTRUST Financial Advisors left its Tenaya Therapeutics share count unchanged in Q3 2026.
  • Tenaya Therapeutics made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q3 2026, its #3357 holding.
  • CAPTRUST Financial Advisors first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 5 quarters since.
  • CAPTRUST Financial Advisors's Tenaya Therapeutics position peaked at $9.9K in Q2 2026.
  • 94 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.